Hemoglobinopathies are a public health problem in Brazil, and these findings are corroborated by data from the National Neonatal Screening Program for diagnosing sickle cell disease and Hb C, Hb D, Hb E and β-thal hemoglobinopathies. Here, GSTM1 is linked to hemoglobinopathy.